Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Angelman Syndrome
Angelman Syndrome
Ultragenyx says Angelman therapy is working, but safety questions remain
BioPharma Dive
Tue, 04/16/24 - 07:49 am
Ultragenyx
Angelman Syndrome
GTX-102
Roche drops antisense drug after seeing efficacy data, leaving Biogen, Ionis and Ultragenyx to duke it out
Fierce Biotech
Fri, 06/23/23 - 09:46 am
Roche
Angelman Syndrome
antisense
Biogen
Ionis Pharmaceuticals
Ultragenyx
rugonersen
Ultragenyx buys gene therapy partner after new study results
BioPharma Dive
Tue, 07/19/22 - 10:45 am
Ultragenyz
gene therapy
M&A
Angelman Syndrome
GeneTx Biotherapeutics
Ultragenyx granted go-ahead to up doses for Angelman antisense therapy that stalled after safety issues
Fierce Biotech
Wed, 01/5/22 - 10:32 pm
Ultragenyx
GeneTx Biotherapeutics
Angelman Syndrome
clinical trials
antisense
GTX-102
Ovid shuffles C-suite, lays off staff in wake of PhIII Angelman syndrome fail
Endpoints
Fri, 07/9/21 - 10:11 am
Ovid Therapeutics
Angelman Syndrome
clinical trials
Ovid cuts its losses on controversial Angelman syndrome drug, making its crushing development halt permanent
Endpoints
Mon, 04/19/21 - 11:17 am
Ovid Therapeutics
Angelman Syndrome
OV101
Ovid crashes out in Angelman syndrome
EP Vantage
Wed, 12/2/20 - 10:25 am
Ovid Therapeutics
OV101
clinical trials
Angelman Syndrome
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma
Xconomy
Mon, 07/13/20 - 11:06 am
Ovid Therapeutics
Angelman Syndrome
Angelini Pharma
Europe
clinical trials
Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome
BioSpace
Thu, 08/15/19 - 12:20 pm
Ultragenyx
GeneTx Biotherapeutics
Angelman Syndrome
M&A
FDA Grants Orphan Drug Designation to Neuralstem's Treatment for Angelman Syndrome
CP Wire
Thu, 08/9/18 - 03:55 pm
Neuralstem
Angelman Syndrome
NSI-189
Positive Results For Ovid Drug, But Questions Remain
Forbes
Mon, 08/6/18 - 10:01 am
Angelman Syndrome
Ovid Therapeutics
gaboxadol